Is Viridian Therapeutics, Inc. (NASDAQ:VRDN) Worth US$19.3 Based On Its...

Published on 25 Dec 2024 on Simply Wall St. · via Yahoo Finance

Key Insights The projected fair value for Viridian Therapeutics is US$14.53 based on 2 Stage Free...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights The projected fair value for Viridian Therapeutics is US$14.53 based on 2 Stage Free...

Simply Wall St. · via Yahoo Finance 25 Dec 2024

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we...

Insider Monkey · via Yahoo Finance 19 Nov 2024

Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant tran...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 24 Jun 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript May 8, 2024 Viridian T...

Insider Monkey via Yahoo Finance 9 May 2024

Revenue: Reported at $72,000 for Q1 2024, surpassing the estimated $70,000.Net Loss: Recorded at ...

GuruFocus.com via Yahoo Finance 8 May 2024

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.79 per share versus the Z...

Zacks via Yahoo Finance 8 May 2024

Shares of Viridian Therapeutics, Inc. (VRDN) have gained 0.4% over the past four weeks to close t...

Zacks via Yahoo Finance 28 Feb 2024

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.09 per share versus the Z...

Zacks via Yahoo Finance 13 Nov 2023

Viridian Therapeutics Inc (NASDAQ:VRDN) continues enrollment for THRIVE and THRIVE-2 clinical tri...

GuruFocus.com via Yahoo Finance 13 Nov 2023